Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Merck. Show all posts
Showing posts with label Merck. Show all posts
Tuesday, September 22, 2026

Merck Scientists Publish Landmark Paper on Novel Method for Large-Scale Biocatalytic Synthesis of Investigational Oral PCSK9 Inhibitor, Enlicitide Decanoate

›
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced the publication of work describing the large-scale synthesis...
Thursday, July 25, 2013

Merck Receives Complete Response Letter for Suvorexant, Merck’s Investigational Medicine for Insomnia

›
In continuation of my update on Suvorexant
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.